CCR5 Co-receptor Antagonist [EPC]

1840 reported adverse events

Drugs of this class: MARAVIROC

These side effects are most commonly reported by patients taking drugs of the CCR5 Co-receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INTERACTION 79
1 ANXIETY 64
2 OFF LABEL USE 61
3 PAIN 57
4 NAUSEA 54
5 VIROLOGIC FAILURE 51
6 DRUG INEFFECTIVE 50
7 DRUG RESISTANCE 49
8 EMOTIONAL DISTRESS 49
9 FOETAL EXPOSURE DURING PREGNANCY 47
See all common reactions for CCR5 Co-receptor Antagonist [EPC]

Drugs of the CCR5 Co-receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIV TROPISM IDENTIFIED 1 1.0000
1 CCR5 RECEPTOR POSITIVE 2 1.0000
2 ANTIRETROVIRAL THERAPY 1 0.5000
3 LENTICULAR OPERATION 2 0.2857
4 PITUITARY HYPERPLASIA 2 0.2500
5 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 6 0.2143
6 HIV VIRAEMIA 6 0.1333
7 CSF HIV ESCAPE SYNDROME 14 0.1186
8 CONGENITAL VESICOURETERIC REFLUX 7 0.1167
9 ANAL CANCER RECURRENT 1 0.1111
See all enriched reactions for CCR5 Co-receptor Antagonist [EPC]